Osaic Holdings’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
VPM
VCM
S
Osaic Holdings's NVAX Position: Q1 2026 in Review
Osaic Holdings increased its Novavax (NVAX) stake by 4.7% in Q1 2026, buying an estimated $19.4K and bringing the position to 47,943 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.
Osaic Holdings first reported a position in NVAX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.7M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Osaic Holdings held 47,943 shares of Novavax worth $390K as of Q1 2026.
- Osaic Holdings bought 2,142 Novavax shares in Q1 2026, an estimated $19.4K.
- Novavax made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3590 holding.
- Osaic Holdings first reported a position in Novavax in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Novavax position peaked at $10.7M in Q4 2021.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.